Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1223484

Cover Image

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1223484

Europe Thyroid Cancer Diagnostics Market - Industry Trends and Forecast to 2030

PUBLISHED:
PAGES: 253 Pages
DELIVERY TIME: Inquiry
SELECT AN OPTION
PDF (Single User License) - Printable/Downloadable
USD 3500
PDF (Enterprise License) - Printable/Downloadable
USD 4200

Add to Cart

The Europe thyroid cancer diagnostics market is projected to register a substantial CAGR of 5.2% from 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation:

Europe Thyroid Cancer Diagnostics Market, By Product Type (Instruments, Consumables & Accessories), Test Type (Imaging Test, Blood Test, Biopsy, Others), Cancer Type (Papillary Carcinoma, Follicular Carcinoma, Others), Stages (Stage I, Stage II, Stage III, Stage IV), Age Group (30-65, 65 and Above, 21-29, Below 21), End Users (Hospital, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, Others), Distribution Channel (Direct Tender, Retail Sales), Country (Germany, France, U.K, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, and the Rest of Europe) Industry Trends and Forecast to 2030.

Some of the major factors contributing to the growth of the Europe thyroid cancer diagnostics market are:

Rising incidence and prevalence of thyroid nodules & cancer

Rising thyroid cancer diagnostic tests rise in product approvals

Rise in healthcare expenditure for cancer diagnosis and treatment

Market Players:

Some of the major players operating in the Europe thyroid cancer diagnostics market are:

FUJIFILM Holdings Corporation

F. Hoffmann-La Roche Ltd

Quest Diagnostics Incorporated

Illumina

Koninklijke Philips N.V.

Thermo Fisher Scientific Inc.

Siemens Healthcare GmbH

Abbott

General Electric Company

BD

QIAGEN

DIASORIN S.P.A.

Merck KGaA

Hologic

Myriad Genetics Inc.

BIOMERIEUX

FONAR Corp.

MinFound Medical Systems Co., Ltd

Medonica Co. LTD

TABLE OF CONTENTS

1 INTRODUCTION 46

  • 1.1 OBJECTIVES OF THE STUDY 46
  • 1.2 MARKET DEFINITION 46
  • 1.3 OVERVIEW OF THE EUROPE THYROID CANCER DIAGNOSTICS MARKET 46
  • 1.4 LIMITATIONS 48
  • 1.5 MARKETS COVERED 48

2 MARKET SEGMENTATION 51

  • 2.1 MARKETS COVERED 51
  • 2.2 GEOGRAPHICAL SCOPE 52
  • 2.3 YEARS CONSIDERED FOR THE STUDY 53
  • 2.4 CURRENCY AND PRICING 53
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL 54
  • 2.6 MULTIVARIATE MODELLING 57
  • 2.7 PRODUCT TYPE LIFELINE CURVE 57
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 58
  • 2.9 DBMR MARKET POSITION GRID 59
  • 2.10 MARKET TESTING TYPE COVERAGE GRID 61
  • 2.11 VENDOR SHARE ANALYSIS 62
  • 2.12 SECONDARY SOURCES 63
  • 2.13 ASSUMPTIONS 63

3 EXECUTIVE SUMMARY 64

4 PREMIUM INSIGHTS 67

  • 4.1 PESTEL ANALYSIS 68
  • 4.2 PORTER'S FIVE FORCES 69
  • 4.3 GROWTH STRATEGIES ADOPTED BY KEY MARKET PLAYERS 70

5 EPIDEMIOLOGY 71

6 REGULATORY FRAMEWORK OF THE EUROPE THYROID CANCER DIAGNOSTICS MARKET 72

  • 6.1 REGULATORY SCENARIO IN THE U.S. 72
  • 6.2 REGULATORY SCENARIO IN AUSTRALIA 73
  • 6.3 REGULATORY SCENARIO IN JAPAN 73
  • 6.4 REGULATORY SCENARIO IN CHINA 73

7 MARKET OVERVIEW 74

  • 7.1 DRIVERS 76
    • 7.1.1 RISING INCIDENCE AND PREVALENCE OF THYROID NODULES AND CANCER 76
    • 7.1.2 RISING THYROID CANCER DIAGNOSTIC TESTS 76
    • 7.1.3 RISING PREFERENCE FOR PREVENTIVE HEALTH CHECK-UPS 77
    • 7.1.4 RISING AWARENESS TOWARDS THYROID CANCER 77
  • 7.2 RESTRAINTS 78
    • 7.2.1 HIGH COST OF DIAGNOSTICS PROCEDURE 78
    • 7.2.2 TISSUE DAMAGE DUE TO HIGH RADIATION EXPOSURE FROM IMAGING TESTS 79
  • 7.3 OPPORTUNITIES 79
    • 7.3.1 RISE IN HEALTHCARE EXPENDITURE FOR CANCER DIAGNOSIS AND TREATMENT 79
    • 7.3.2 RISING OBESE POPULATION 80
  • 7.4 CHALLENGES 80
    • 7.4.1 STRINGENT REGULATORY FRAMEWORK FOR THE APPROVAL AND COMMERCIALIZATION OF CANCER DIAGNOSTIC PRODUCTS 80
    • 7.4.2 LACK OF SKILLED AND CERTIFIED EXPERTISE 81

8 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE 82

  • 8.1 OVERVIEW 83
  • 8.2 INSTRUMENTS 86
    • 8.2.1 PATHOLOGY BASED INSTRUMENTS 87
      • 8.2.1.1 PCR INSTRUMENTS 87
      • 8.2.1.2 SLIDE STAINING SYSTEMS 87
      • 8.2.1.3 TISSUE PROCESSING SYSTEMS 87
      • 8.2.1.4 CELL PROCESSORS 88
      • 8.2.1.5 OTHER PATHOLOGY-BASED INSTRUMENTS 88
    • 8.2.2 IMAGING INSTRUMENTS 88
      • 8.2.2.1 ULTRASOUND SYSTEMS 88
      • 8.2.2.2 CT SYSTEMS 88
      • 8.2.2.3 MRI SYSTEMS 88
      • 8.2.2.4 OTHERS 88
    • 8.2.3 BIOPSY INSTRUMENTS 89
      • 8.2.3.1 NEEDLE BIOPSY 89
      • 8.2.3.2 ENDOSCOPIC BIOPSY 89
      • 8.2.3.3 CORE BIOPSY 89
      • 8.2.3.4 OTHERS 89
    • 8.2.4 OTHERS 89
  • 8.3 CONSUMABLES & ACCESSORIES 90
    • 8.3.1 KITS 91
      • 8.3.1.1 PCR KITS 91
      • 8.3.1.2 DNA POLYMERASE KITS 91
      • 8.3.1.3 NUCLEIC ACID ISOLATION KITS 91
      • 8.3.1.4 OTHERS 91
    • 8.3.2 REAGENTS 92
      • 8.3.2.1 ASSAYS 92
      • 8.3.2.2 BUFFERS 92
      • 8.3.2.3 PRIMERS 92
      • 8.3.2.4 OTHERS 92
    • 8.3.3 PROBES 92
    • 8.3.4 OTHER CONSUMABLES 92

9 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE 93

  • 9.1 OVERVIEW 94
  • 9.2 IMAGING TEST 97
    • 9.2.1 COMPUTED TOMOGRAPHY (CT) SCAN 98
    • 9.2.2 MRI 98
    • 9.2.3 POSITRON EMISSION TOMOGRAPHY (PET) SCAN 98
    • 9.2.4 OTHERS 98
  • 9.3 BLOOD TEST 99
    • 9.3.1 BLOOD CHEMISTRY TESTS 100
    • 9.3.2 COMPLETE BLOOD COUNT (CBC) 100
    • 9.3.3 OTHERS 100
  • 9.4 BIOPSY 100
    • 9.4.1 NEEDLE BIOPSY 101
    • 9.4.2 BRONCHOSCOPY BIOPSY 101
    • 9.4.3 CORE BIOPSY 101
    • 9.4.4 OTHERS 101
  • 9.5 OTHERS 102

10 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE 103

  • 10.1 OVERVIEW 104
  • 10.2 PAPILLARY CARCINOMA 107
  • 10.3 FOLLICULAR CARCINOMA 108
  • 10.4 OTHERS 109

11 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY STAGES 110

  • 11.1 OVERVIEW 111
  • 11.2 STAGE I 114
  • 11.3 STAGE II 115
  • 11.4 STAGE III 116
  • 11.5 STAGE IV 117

12 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP 118

  • 12.1 OVERVIEW 119
  • 12.2 30-65 122
  • 12.3 65 AND ABOVE 123
  • 12.4 21-29 124
  • 12.5 BELOW 21 125

13 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY END USER 126

  • 13.1 OVERVIEW 127
  • 13.2 HOSPITALS 130
  • 13.3 ASSOCIATED LABS 131
  • 13.4 INDEPENDENT DIAGNOSTIC LABORATORIES 131
  • 13.5 DIAGNOSTIC IMAGING CENTERS 132
  • 13.6 CANCER RESEARCH INSTITUTES 133
  • 13.7 OTHERS 134

14 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL 135

  • 14.1 OVERVIEW 136
  • 14.2 DIRECT TENDER 139
  • 14.3 RETAIL SALES 140

15 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY REGION 141

  • 15.1 EUROPE 142
    • 15.1.1 GERMANY 152
    • 15.1.2 U.K. 157
    • 15.1.3 ITALY 162
    • 15.1.4 FRANCE 167
    • 15.1.5 SPAIN 172
    • 15.1.6 RUSSIA 177
    • 15.1.7 SWITZERLAND 182
    • 15.1.8 TURKEY 187
    • 15.1.9 BELGIUM 192
    • 15.1.10 NETHERLANDS 197
    • 15.1.11 REST OF EUROPE 202

16 EUROPE THYROID CANCER DIAGNOSTICS MARKET: COMPANY LANDSCAPE 203

  • 16.1 COMPANY SHARE ANALYSIS: EUROPE 203

17 SWOT ANALYSIS 204

18 COMPANY PROFILE 205

  • 18.1 CANON INC. 205
    • 18.1.1 COMPANY SNAPSHOT 205
    • 18.1.2 COMPANY SHARE ANALYSIS 205
    • 18.1.3 PRODUCT PORTFOLIO 206
    • 18.1.4 RECENT DEVELOPMENTS 206
  • 18.2 FUJIFILM CORPORATION 207
    • 18.2.1 COMPANY SNAPSHOT 207
    • 18.2.2 REVENUE ANALYSIS 207
    • 18.2.3 COMPANY SHARE ANALYSIS 208
    • 18.2.4 PRODUCT PORTFOLIO 208
    • 18.2.5 RECENT DEVELOPMENT 208
  • 18.3 F. HOFFMANN-LA ROCHE LTD 209
    • 18.3.1 COMPANY SNAPSHOT 209
    • 18.3.2 REVENUE ANALYSIS 209
    • 18.3.3 COMPANY SHARE ANALYSIS 210
    • 18.3.4 PRODUCT PORTFOLIO 210
    • 18.3.5 RECENT DEVELOPMENT 210
  • 18.4 QUEST DIAGNOSTICS INCORPORATED 211
    • 18.4.1 COMPANY SNAPSHOT 211
    • 18.4.2 REVENUE ANALYSIS 211
    • 18.4.3 COMPANY SHARE ANALYSIS 212
    • 18.4.4 PRODUCT PORTFOLIO 212
    • 18.4.5 RECENT DEVELOPMENTS 212
  • 18.5 ILLUMINA, INC. 214
    • 18.5.1 COMPANY SNAPSHOT 214
    • 18.5.2 REVENUE ANALYSIS 214
    • 18.5.3 COMPANY SHARE ANALYSIS 215
    • 18.5.4 PRODUCT PORTFOLIO 215
    • 18.5.5 RECENT DEVELOPMENT 215
  • 18.6 ABBOTT 216
    • 18.6.1 COMPANY SNAPSHOT 216
    • 18.6.2 REVENUE ANALYSIS 216
    • 18.6.3 PRODUCT PORTFOLIO 217
    • 18.6.4 RECENT DEVELOPMENT 217
  • 18.7 BD 218
    • 18.7.1 COMPANY SNAPSHOT 218
    • 18.7.2 REVENUE ANALYSIS 218
    • 18.7.3 PRODUCT PORTFOLIO 219
    • 18.7.4 RECENT DEVELOPMENT 219
  • 18.8 BEIJING O&D BIOTECH CO., LTD. 220
    • 18.8.1 COMPANY SNAPSHOT 220
    • 18.8.2 PRODUCT PORTFOLIO 220
    • 18.8.3 RECENT DEVELOPMENTS 220
  • 18.9 BIOMERIEUX SA 221
    • 18.9.1 COMPANY SNAPSHOT 221
    • 18.9.2 REVENUE ANALYSIS 221
    • 18.9.3 PRODUCT PORTFOLIO 222
    • 18.9.4 RECENT DEVELOPMENTS 222
  • 18.10 DIASORIN S.P.A. 223
    • 18.10.1 COMPANY SNAPSHOT 223
    • 18.10.2 REVENUE ANALYSIS 223
    • 18.10.3 PRODUCT PORTFOLIO 224
    • 18.10.4 RECENT DEVELOPMENT 224
  • 18.11 FONAR CORP. 225
    • 18.11.1 COMPANY SNAPSHOT 225
    • 18.11.2 REVENUE ANALYSIS 225
    • 18.11.3 PRODUCT PORTFOLIO 226
    • 18.11.4 RECENT DEVELOPMENTS 226
  • 18.12 GENERAL ELECTRIC 227
    • 18.12.1 COMPANY SNAPSHOT 227
    • 18.12.2 REVENUE ANALYSIS 227
    • 18.12.3 PRODUCT PORTFOLIO 228
    • 18.12.4 RECENT DEVELOPMENTS 228
  • 18.13 HOLOGIC INC. 229
    • 18.13.1 COMPANY SNAPSHOT 229
    • 18.13.2 REVENUE ANALYSIS 229
    • 18.13.3 PRODUCT PORTFOLIO 230
    • 18.13.4 RECENT DEVELOPMENT 230
  • 18.14 KONINKLIJKE PHILIPS N.V. 231
    • 18.14.1 COMPANY SNAPSHOT 231
    • 18.14.2 REVENUE ANALYSIS 231
    • 18.14.3 PRODUCT PORTFOLIO 232
    • 18.14.4 RECENT DEVELOPMENT 232
  • 18.15 MERCK KGAA. 233
    • 18.15.1 COMPANY SNAPSHOT 233
    • 18.15.2 REVENUE ANALYSIS 233
    • 18.15.3 PRODUCT PORTFOLIO 234
    • 18.15.4 RECENT DEVELOPMENT 234
  • 18.16 MEDONICA CO. LTD 235
    • 18.16.1 COMPANY SNAPSHOT 235
    • 18.16.2 PRODUCT PORTFOLIO 235
    • 18.16.3 RECENT DEVELOPMENT 235
  • 18.17 MINFOUND MEDICAL SYSTEMS CO. LTD 236
    • 18.17.1 COMPANY SNAPSHOT 236
    • 18.17.2 PRODUCT PORTFOLIO 236
    • 18.17.3 RECENT DEVELOPMENTS 237
  • 18.18 MYRIAD GENETICS, INC. 238
    • 18.18.1 COMPANY SNAPSHOT 238
    • 18.18.2 REVENUE ANALYSIS 238
    • 18.18.3 PRODUCT PORTFOLIO 239
    • 18.18.4 RECENT DEVELOPMENTS 239
  • 18.19 PLEXBIO. 240
    • 18.19.1 COMPANY SNAPSHOT 240
    • 18.19.2 PRODUCT PORTFOLIO 240
    • 18.19.3 RECENT DEVELOPMENTS 240
  • 18.20 QIAGEN 241
    • 18.20.1 COMPANY SNAPSHOT 241
    • 18.20.2 REVENUE ANALYSIS 241
    • 18.20.3 PRODUCT PORTFOLIO 242
    • 18.20.4 RECENT DEVELOPMENT 242
  • 18.21 STERNMED GMBH 243
    • 18.21.1 COMPANY SNAPSHOT 243
    • 18.21.2 PRODUCT PORTFOLIO 243
    • 18.21.3 RECENT DEVELOPMENTS 243
  • 18.22 SIEMENS HEALTHCARE GMBH 244
    • 18.22.1 COMPANY SNAPSHOT 244
    • 18.22.2 REVENUE ANALYSIS 244
    • 18.22.3 PRODUCT PORTFOLIO 245
    • 18.22.4 RECENT DEVELOPMENT 245
  • 18.23 TIME MEDICAL HOLDING. 246
    • 18.23.1 COMPANY SNAPSHOT 246
    • 18.23.2 PRODUCT PORTFOLIO 246
    • 18.23.3 RECENT DEVELOPMENT 246
  • 18.24 THERMO FISHER SCIENTIFIC INC. 247
    • 18.24.1 COMPANY SNAPSHOT 247
    • 18.24.2 REVENUE ANALYSIS 247
    • 18.24.3 PRODUCT PORTFOLIO 248
    • 18.24.4 RECENT DEVELOPMENT 248

19 QUESTIONNAIRE 249

20 RELATED REPORTS 253

LIST OF TABLES

  • TABLE 1 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 65
  • TABLE 2 EUROPE INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 66
  • TABLE 3 EUROPE INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 67
  • TABLE 4 EUROPE PATHOLOGY-BASED INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 67
  • TABLE 5 EUROPE IMAGING INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 68
  • TABLE 6 EUROPE BIOPSY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 69
  • TABLE 7 EUROPE CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 70
  • TABLE 8 EUROPE CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 71
  • TABLE 9 EUROPE KITS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 71
  • TABLE 10 EUROPE REAGENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 72
  • TABLE 11 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 76
  • TABLE 12 EUROPE IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 77
  • TABLE 13 EUROPE IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 78
  • TABLE 14 EUROPE BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 79
  • TABLE 15 EUROPE BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 80
  • TABLE 16 EUROPE BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 81
  • TABLE 17 EUROPE BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 81
  • TABLE 18 EUROPE OTHERS IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 82
  • TABLE 19 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 86
  • TABLE 20 EUROPE PAPILLARY CARCINOMA IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 87
  • TABLE 21 EUROPE FOLLICULAR CARCINOMA IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 88
  • TABLE 22 EUROPE OTHERS IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 89
  • TABLE 23 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 93
  • TABLE 24 EUROPE STAGE I IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 94
  • TABLE 25 EUROPE STAGE II IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 95
  • TABLE 26 EUROPE STAGE III IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 96
  • TABLE 27 EUROPE STAGE IV IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 97
  • TABLE 28 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 101
  • TABLE 29 EUROPE 30-65 IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 102
  • TABLE 30 EUROPE 65 AND ABOVE IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 103
  • TABLE 31 EUROPE 21-29 IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 104
  • TABLE 32 EUROPE BELOW 21 IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 105
  • TABLE 33 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 109
  • TABLE 34 EUROPE HOSPITALS IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 110
  • TABLE 35 EUROPE ASSOCIATED LABS IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 111
  • TABLE 36 EUROPE INDEPENDENT DIAGNOSTIC LABORATORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 112
  • TABLE 37 EUROPE DIAGNOSTIC IMAGING CENTERS IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 112
  • TABLE 38 EUROPE CANCER RESEARCH INSTITUTES IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 113
  • TABLE 39 EUROPE OTHERS IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 114
  • TABLE 40 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 118
  • TABLE 41 EUROPE DIRECT TENDER IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 119
  • TABLE 42 EUROPE RETAIL SALES IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 120
  • TABLE 43 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 127
  • TABLE 44 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 127
  • TABLE 45 EUROPE INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 127
  • TABLE 46 EUROPE PATHOLOGY-BASED INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 128
  • TABLE 47 EUROPE IMAGING INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 128
  • TABLE 48 EUROPE BIOPSY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 128
  • TABLE 49 EUROPE CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 129
  • TABLE 50 EUROPE KITS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 129
  • TABLE 51 EUROPE REAGENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 129
  • TABLE 52 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 129
  • TABLE 53 EUROPE IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 130
  • TABLE 54 EUROPE BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 130
  • TABLE 55 EUROPE BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 130
  • TABLE 56 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 130
  • TABLE 57 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 131
  • TABLE 58 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 131
  • TABLE 59 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 131
  • TABLE 60 EUROPE THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 131
  • TABLE 61 GERMANY THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 132
  • TABLE 62 GERMANY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 132
  • TABLE 63 GERMANY PATHOLOGY-BASED INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 132
  • TABLE 64 GERMANY IMAGING INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 133
  • TABLE 65 GERMANY BIOPSY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 133
  • TABLE 66 GERMANY CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 133
  • TABLE 67 GERMANY KITS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 134
  • TABLE 68 GERMANY REAGENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 134
  • TABLE 69 GERMANY THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 134
  • TABLE 70 GERMANY IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 135
  • TABLE 71 GERMANY BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 135
  • TABLE 72 GERMANY BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 135
  • TABLE 73 GERMANY THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 135
  • TABLE 74 GERMANY THYROID CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 136
  • TABLE 75 GERMANY THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 136
  • TABLE 76 GERMANY THYROID CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 136
  • TABLE 77 GERMANY THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 136
  • TABLE 78 U.K. THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 137
  • TABLE 79 U.K. INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 137
  • TABLE 80 U.K. PATHOLOGY-BASED INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 137
  • TABLE 81 U.K. IMAGING INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 138
  • TABLE 82 U.K. BIOPSY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 138
  • TABLE 83 U.K. CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 138
  • TABLE 84 U.K. KITS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 139
  • TABLE 85 U.K. REAGENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 139
  • TABLE 86 U.K. THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 139
  • TABLE 87 U.K. IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 139
  • TABLE 88 U.K. BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 140
  • TABLE 89 U.K. BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 140
  • TABLE 90 U.K. THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 140
  • TABLE 91 U.K. THYROID CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 140
  • TABLE 92 U.K. THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 141
  • TABLE 93 U.K. THYROID CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 141
  • TABLE 94 U.K. THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 141
  • TABLE 95 ITALY THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 142
  • TABLE 96 ITALY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 142
  • TABLE 97 ITALY PATHOLOGY-BASED INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 142
  • TABLE 98 ITALY IMAGING INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 143
  • TABLE 99 ITALY BIOPSY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 143
  • TABLE 100 ITALY CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 143
  • TABLE 101 ITALY KITS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 144
  • TABLE 102 ITALY REAGENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 144
  • TABLE 103 ITALY THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 144
  • TABLE 104 ITALY IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 144
  • TABLE 105 ITALY BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 145
  • TABLE 106 ITALY BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 145
  • TABLE 107 ITALY THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 145
  • TABLE 108 ITALY THYROID CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 145
  • TABLE 109 ITALY THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 146
  • TABLE 110 ITALY THYROID CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 146
  • TABLE 111 ITALY THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 146
  • TABLE 112 FRANCE THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 147
  • TABLE 113 FRANCE INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 147
  • TABLE 114 FRANCE PATHOLOGY-BASED INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 147
  • TABLE 115 FRANCE IMAGING INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 148
  • TABLE 116 FRANCE BIOPSY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 148
  • TABLE 117 FRANCE CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 148
  • TABLE 118 FRANCE KITS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 149
  • TABLE 119 FRANCE REAGENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 149
  • TABLE 120 FRANCE THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 149
  • TABLE 121 FRANCE IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 149
  • TABLE 122 FRANCE BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 150
  • TABLE 123 FRANCE BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 150
  • TABLE 124 FRANCE THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 150
  • TABLE 125 FRANCE THYROID CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 150
  • TABLE 126 FRANCE THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 151
  • TABLE 127 FRANCE THYROID CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 151
  • TABLE 128 FRANCE THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 151
  • TABLE 129 SPAIN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 152
  • TABLE 130 SPAIN INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 152
  • TABLE 131 SPAIN PATHOLOGY-BASED INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 152
  • TABLE 132 SPAIN IMAGING INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 153
  • TABLE 133 SPAIN BIOPSY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 153
  • TABLE 134 SPAIN CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 153
  • TABLE 135 SPAIN KITS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 154
  • TABLE 136 SPAIN REAGENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 154
  • TABLE 137 SPAIN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 154
  • TABLE 138 SPAIN IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 154
  • TABLE 139 SPAIN BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 155
  • TABLE 140 SPAIN BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 155
  • TABLE 141 SPAIN THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 155
  • TABLE 142 SPAIN THYROID CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 155
  • TABLE 143 SPAIN THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 156
  • TABLE 144 SPAIN THYROID CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 156
  • TABLE 145 SPAIN THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 156
  • TABLE 146 RUSSIA THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 157
  • TABLE 147 RUSSIA INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 157
  • TABLE 148 RUSSIA PATHOLOGY-BASED INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 157
  • TABLE 149 RUSSIA IMAGING INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 158
  • TABLE 150 RUSSIA BIOPSY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 158
  • TABLE 151 RUSSIA CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 158
  • TABLE 152 RUSSIA KITS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 159
  • TABLE 153 RUSSIA REAGENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 159
  • TABLE 154 RUSSIA THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 159
  • TABLE 155 RUSSIA IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 160
  • TABLE 156 RUSSIA BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 160
  • TABLE 157 RUSSIA BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 160
  • TABLE 158 RUSSIA THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 160
  • TABLE 159 RUSSIA THYROID CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 161
  • TABLE 160 RUSSIA THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 161
  • TABLE 161 RUSSIA THYROID CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 161
  • TABLE 162 RUSSIA THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 161
  • TABLE 163 SWITZERLAND THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 162
  • TABLE 164 SWITZERLAND INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 162
  • TABLE 165 SWITZERLAND PATHOLOGY-BASED INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 162
  • TABLE 166 SWITZERLAND IMAGING INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 163
  • TABLE 167 SWITZERLAND BIOPSY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 163
  • TABLE 168 SWITZERLAND CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 163
  • TABLE 169 SWITZERLAND KITS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 164
  • TABLE 170 SWITZERLAND REAGENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 164
  • TABLE 171 SWITZERLAND THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 164
  • TABLE 172 SWITZERLAND IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 164
  • TABLE 173 SWITZERLAND BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 165
  • TABLE 174 SWITZERLAND BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 165
  • TABLE 175 SWITZERLAND THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 165
  • TABLE 176 SWITZERLAND THYROID CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 165
  • TABLE 177 SWITZERLAND THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 166
  • TABLE 178 SWITZERLAND THYROID CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 166
  • TABLE 179 SWITZERLAND THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 166
  • TABLE 180 TURKEY THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 167
  • TABLE 181 TURKEY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 167
  • TABLE 182 TURKEY PATHOLOGY-BASED INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 167
  • TABLE 183 TURKEY IMAGING INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 168
  • TABLE 184 TURKEY BIOPSY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 168
  • TABLE 185 TURKEY CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 168
  • TABLE 186 TURKEY KITS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 169
  • TABLE 187 TURKEY REAGENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 169
  • TABLE 188 TURKEY THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 169
  • TABLE 189 TURKEY IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 169
  • TABLE 190 TURKEY BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 170
  • TABLE 191 TURKEY BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 170
  • TABLE 192 TURKEY THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 170
  • TABLE 193 TURKEY THYROID CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 170

LIST OF FIGURES

  • FIGURE 1 EUROPE THYROID CANCER DIAGNOSTICS MARKET: SEGMENTATION 29
  • FIGURE 2 EUROPE THYROID CANCER DIAGNOSTICS MARKET: DATA TRIANGULATION 32
  • FIGURE 3 EUROPE THYROID CANCER DIAGNOSTICS MARKET: DROC ANALYSIS 33
  • FIGURE 4 EUROPE THYROID CANCER DIAGNOSTICS MARKET: EUROPE VS REGIONAL MARKET ANALYSIS 34
  • FIGURE 5 EUROPE THYROID CANCER DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS 34
  • FIGURE 6 EUROPE THYROID CANCER DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS 36
  • FIGURE 7 EUROPE THYROID CANCER DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID 37
  • FIGURE 8 EUROPE THYROID CANCER DIAGNOSTICS MARKET: MARKET TESTING TYPE COVERAGE GRID 39
  • FIGURE 9 EUROPE THYROID CANCER DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS 40
  • FIGURE 10 EUROPE THYROID CANCER DIAGNOSTICS MARKET: SEGMENTATION 44
  • FIGURE 11 THE INCREASE IN THE AWARENESS ABOUT THYROID CANCER IS EXPECTED TO DRIVE THE EUROPE THYROID CANCER DIAGNOSTICS MARKET IN THE FORECAST PERIOD 45
  • FIGURE 12 PRODUCT TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE THYROID CANCER DIAGNOSTICS MARKET IN 2023 & 2030 45
  • FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF EUROPE THYROID CANCER DIAGNOSTICS MARKET 53
  • FIGURE 14 EUROPE THYROID CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2022 61
  • FIGURE 15 EUROPE THYROID CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION) 62
  • FIGURE 16 EUROPE THYROID CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, CAGR (2023-2030) 62
  • FIGURE 17 EUROPE THYROID CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, LIFELINE CURVE 63
  • FIGURE 18 EUROPE THYROID CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2022 72
  • FIGURE 19 EUROPE THYROID CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2023-2030 (USD MILLION) 73
  • FIGURE 20 EUROPE THYROID CANCER DIAGNOSTICS MARKET: BY TEST TYPE, CAGR (2023-2030) 73
  • FIGURE 21 EUROPE THYROID CANCER DIAGNOSTICS MARKET: BY TEST TYPE, LIFELINE CURVE 74
  • FIGURE 22 EUROPE THYROID CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2022 82
  • FIGURE 23 EUROPE THYROID CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2023-2030 (USD MILLION) 83
  • FIGURE 24 EUROPE THYROID CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, CAGR (2023-2030) 83
  • FIGURE 25 EUROPE THYROID CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, LIFELINE CURVE 84
  • FIGURE 26 EUROPE THYROID CANCER DIAGNOSTICS MARKET: BY STAGES, 2022 89
  • FIGURE 27 EUROPE THYROID CANCER DIAGNOSTICS MARKET: BY STAGES, 2023-2030 (USD MILLION) 90
  • FIGURE 28 EUROPE THYROID CANCER DIAGNOSTICS MARKET: BY STAGES, CAGR (2023-2030) 90
  • FIGURE 29 EUROPE THYROID CANCER DIAGNOSTICS MARKET: BY STAGES, LIFELINE CURVE 91
  • FIGURE 30 EUROPE THYROID CANCER DIAGNOSTICS MARKET: BY AGE GROUP, 2022 97
  • FIGURE 31 EUROPE THYROID CANCER DIAGNOSTICS MARKET: BY AGE GROUP, 2023-2030 (USD MILLION) 98
  • FIGURE 32 EUROPE THYROID CANCER DIAGNOSTICS MARKET: BY AGE GROUP, CAGR (2023-2030) 98
  • FIGURE 33 EUROPE THYROID CANCER DIAGNOSTICS MARKET: BY AGE GROUP, LIFELINE CURVE 99
  • FIGURE 34 EUROPE THYROID CANCER DIAGNOSTICS MARKET: BY END USER, 2022 105
  • FIGURE 35 EUROPE THYROID CANCER DIAGNOSTICS MARKET: BY END USER, 2023-2030 (USD MILLION) 106
  • FIGURE 36 EUROPE THYROID CANCER DIAGNOSTICS MARKET: BY END USER, CAGR (2023-2030) 106
  • FIGURE 37 EUROPE THYROID CANCER DIAGNOSTICS MARKET: BY END USER, LIFELINE CURVE 107
  • FIGURE 38 EUROPE THYROID CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2022 114
  • FIGURE 39 EUROPE THYROID CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION) 115
  • FIGURE 40 EUROPE THYROID CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 115
  • FIGURE 41 EUROPE THYROID CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 116
  • FIGURE 42 EUROPE THYROID CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022) 121
  • FIGURE 43 EUROPE THYROID CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022) 123
  • FIGURE 44 EUROPE THYROID CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030) 123
  • FIGURE 45 EUROPE THYROID CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2030) 124
  • FIGURE 46 EUROPE THYROID CANCER DIAGNOSTICS MARKET: PRODUCT TYPE (2023-2030) 124
  • FIGURE 47 EUROPE THYROID CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2022 (%) 181
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!